HIGHLIGHTS
- who: Annika C. Betzler and colleagues from the Department of Oto-Rhino-Laryngology, Ulm University Medical Center, Ulm, Germany have published the article: BTK Isoforms p80 and p65 Are Expressed in Head and Neck Squamous Cell Carcinoma (HNSCC) and Involved in Tumor Progression, in the Journal: Cancers 2023, 310 of 16/Nov/2022
- what: This study aims to investigate the expression of BTK isoforms in head and neck squamous cell carcinoma (HNSCC). The authors aimed to investigate whether treatment of HNSCC with BTK inhibitory drugs would be a beneficial new therapeutic option. The authors aimed . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.